Somerville Kurt F Lowers stake in AptarGroup (ATR)

AptarGroup (ATR) : Somerville Kurt F reduced its stake in AptarGroup by 1.9% during the most recent quarter end. The investment management company now holds a total of 199,256 shares of AptarGroup which is valued at $15.4 Million after selling 3,857 shares in AptarGroup , the firm said in a disclosure report filed with the SEC on May 27, 2016.AptarGroup makes up approximately 3.50% of Somerville Kurt F’s portfolio.

Other Hedge Funds, Including , Broderick Brian C boosted its stake in ATR in the latest quarter, The investment management firm added 4,170 additional shares and now holds a total of 99,480 shares of AptarGroup which is valued at $7.7 Million. AptarGroup makes up approx 3.30% of Broderick Brian C’s portfolio.Babson Capital Management reduced its stake in ATR by selling 500 shares or 3.29% in the most recent quarter. The Hedge Fund company now holds 14,700 shares of ATR which is valued at $1.1 Million. AptarGroup makes up approx 0.06% of Babson Capital Management’s portfolio. Wolverine Asset Management added ATR to its portfolio by purchasing 25,000 company shares during the most recent quarter which is valued at $1.9 Million. AptarGroup makes up approx 0.19% of Wolverine Asset Management’s portfolio. Tower Research Capital (trc) added ATR to its portfolio by purchasing 1,285 company shares during the most recent quarter which is valued at $96,799. AptarGroup makes up approx 0.01% of Tower Research Capital (trc)’s portfolio.Oppenheimerfunds reduced its stake in ATR by selling 959 shares or 18.09% in the most recent quarter. The Hedge Fund company now holds 4,342 shares of ATR which is valued at $334,204.

AptarGroup opened for trading at $77.03 and hit $77.91 on the upside on Tuesday, eventually ending the session at $77.49, with a gain of 0.52% or 0.4 points. The heightened volatility saw the trading volume jump to 1,70,102 shares. Company has a market cap of $4,894 M.

On the company’s financial health, AptarGroup reported $0.71 EPS for the quarter, missing the analyst consensus estimate by $ -0.01 based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus of $0.72. The company had revenue of $582.40 million for the quarter, compared to analysts expectations of $586.72 million. The company’s revenue was down -1.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.70 EPS.

AptarGroup Inc. is a solution provider of a range of packaging delivery solutions for the beauty personal care home care prescription drug consumer health care injectables food and beverage markets. The Company has manufacturing facilities located throughout the world including North America Europe Asia and South America. It offers various dispensing and sealing solutions. Its primary products are dispensing pumps closures aerosol valves and elastomer primary packaging components. It also manufactures and sells elastomer primary packaging components which include stoppers for infusion antibiotic lyophilization and diagnostic vials. Its elastomer components also include pre-filled syringe components such as plungers needle shields tip caps and cartridges as well as dropper bulbs and disposable syringe plungers. The Company’s segments include Beauty + Home Pharma and Food + Beverage.

Leave a Reply

AptarGroup - Is it time to Sell?

Top Brokerage Firms are advising their investors on AptarGroup. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.